Vanda Pharmaceuticals on Monday rolled out positive Phase 2 data supporting its experimental drug for gastroparesis, a condition that's gone without new treatment options for nearly four decades.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,